The Emerging Terbinafine-Resistant Trichophyton Epidemic: What Is the Role of Antifungal Susceptibility Testing?

Publikation: Bidrag til tidsskriftReviewForskningfagfællebedømt

Standard

The Emerging Terbinafine-Resistant Trichophyton Epidemic : What Is the Role of Antifungal Susceptibility Testing? / Shen, Julia J.; Arendrup, Maiken C.; Verma, Shyam; Saunte, Ditte Marie L.

I: Dermatology, Bind 238, 2022, s. 60–79.

Publikation: Bidrag til tidsskriftReviewForskningfagfællebedømt

Harvard

Shen, JJ, Arendrup, MC, Verma, S & Saunte, DML 2022, 'The Emerging Terbinafine-Resistant Trichophyton Epidemic: What Is the Role of Antifungal Susceptibility Testing?', Dermatology, bind 238, s. 60–79. https://doi.org/10.1159/000515290

APA

Shen, J. J., Arendrup, M. C., Verma, S., & Saunte, D. M. L. (2022). The Emerging Terbinafine-Resistant Trichophyton Epidemic: What Is the Role of Antifungal Susceptibility Testing? Dermatology, 238, 60–79. https://doi.org/10.1159/000515290

Vancouver

Shen JJ, Arendrup MC, Verma S, Saunte DML. The Emerging Terbinafine-Resistant Trichophyton Epidemic: What Is the Role of Antifungal Susceptibility Testing? Dermatology. 2022;238:60–79. https://doi.org/10.1159/000515290

Author

Shen, Julia J. ; Arendrup, Maiken C. ; Verma, Shyam ; Saunte, Ditte Marie L. / The Emerging Terbinafine-Resistant Trichophyton Epidemic : What Is the Role of Antifungal Susceptibility Testing?. I: Dermatology. 2022 ; Bind 238. s. 60–79.

Bibtex

@article{d36aaee276ad48819209b6c80409edc4,
title = "The Emerging Terbinafine-Resistant Trichophyton Epidemic: What Is the Role of Antifungal Susceptibility Testing?",
abstract = "Background: Dermatophytosis is commonly encountered in the dermatological clinics. The main aetiological agents in dermatophytosis of skin and nails in humans are Trichophyton (T.) rubrum, T. mentagrophytes and T. interdigitale (former T. mentagrophytes-complex). Terbinafine therapy is usually effective in eradicating infections due to these species by inhibiting their squalene epoxidase (SQLE) enzyme, but increasing numbers of clinically resistant cases and mutations in the SQLE gene have been documented recently. Resistance to antimycotics is phenotypically determined by antifungal susceptibility testing (AFST). However, AFST is not routinely performed for dermatophytes and no breakpoints classifying isolates as susceptible or resistant are available, making it difficult to interpret the clinical impact of a minimal inhibitory concentration (MIC). Summary: PubMed was systematically searched for terbinafine susceptibility testing of dermatophytes on October 20, 2020, by two individual researchers. The inclusion criteria were in vitro terbinafine susceptibility testing of Trichophyton (T.) rubrum, T. mentagrophytes and T. interdigitale with the broth microdilution technique. The exclusion criteria were non-English written papers. Outcomes were reported as MIC range, geometric mean, modal MIC and MIC50 and MIC90 in which 50 or 90% of isolates were inhibited, respectively. The reported MICs ranged from <0.001 to >64 mg/L. The huge variation in MIC is partly explained by the heterogeneity of the Trichophyton isolates, where some originated from routine specimens (wild types) whereas others came from non-responding patients with a known SQLE gene mutation. Another reason for the great variation in MIC is the use of different AFST methods where MIC values are not directly comparable. High MICs were reported particularly in isolates with SQLE gene mutation. The following SQLE alterations were reported: F397L, L393F, L393S, H440Y, F393I, F393V, F415I, F415S, F415V, S443P, A448T, L335F/A448T, S395P/A448T, L393S/A448T, Q408L/A448T, F397L/A448T, I121M/V237I and H440Y/F484Y in terbinafine-resistant isolates. ",
keywords = "Antifungal susceptibility testing, Dermatophytes, Resistance, Terbinafine, Trichophyton",
author = "Shen, {Julia J.} and Arendrup, {Maiken C.} and Shyam Verma and Saunte, {Ditte Marie L.}",
note = "Publisher Copyright: {\textcopyright} 2021 S. Karger AG, Basel. Copyright: All rights reserved.",
year = "2022",
doi = "10.1159/000515290",
language = "English",
volume = "238",
pages = "60–79",
journal = "Dermatology",
issn = "1018-8665",
publisher = "S Karger AG",

}

RIS

TY - JOUR

T1 - The Emerging Terbinafine-Resistant Trichophyton Epidemic

T2 - What Is the Role of Antifungal Susceptibility Testing?

AU - Shen, Julia J.

AU - Arendrup, Maiken C.

AU - Verma, Shyam

AU - Saunte, Ditte Marie L.

N1 - Publisher Copyright: © 2021 S. Karger AG, Basel. Copyright: All rights reserved.

PY - 2022

Y1 - 2022

N2 - Background: Dermatophytosis is commonly encountered in the dermatological clinics. The main aetiological agents in dermatophytosis of skin and nails in humans are Trichophyton (T.) rubrum, T. mentagrophytes and T. interdigitale (former T. mentagrophytes-complex). Terbinafine therapy is usually effective in eradicating infections due to these species by inhibiting their squalene epoxidase (SQLE) enzyme, but increasing numbers of clinically resistant cases and mutations in the SQLE gene have been documented recently. Resistance to antimycotics is phenotypically determined by antifungal susceptibility testing (AFST). However, AFST is not routinely performed for dermatophytes and no breakpoints classifying isolates as susceptible or resistant are available, making it difficult to interpret the clinical impact of a minimal inhibitory concentration (MIC). Summary: PubMed was systematically searched for terbinafine susceptibility testing of dermatophytes on October 20, 2020, by two individual researchers. The inclusion criteria were in vitro terbinafine susceptibility testing of Trichophyton (T.) rubrum, T. mentagrophytes and T. interdigitale with the broth microdilution technique. The exclusion criteria were non-English written papers. Outcomes were reported as MIC range, geometric mean, modal MIC and MIC50 and MIC90 in which 50 or 90% of isolates were inhibited, respectively. The reported MICs ranged from <0.001 to >64 mg/L. The huge variation in MIC is partly explained by the heterogeneity of the Trichophyton isolates, where some originated from routine specimens (wild types) whereas others came from non-responding patients with a known SQLE gene mutation. Another reason for the great variation in MIC is the use of different AFST methods where MIC values are not directly comparable. High MICs were reported particularly in isolates with SQLE gene mutation. The following SQLE alterations were reported: F397L, L393F, L393S, H440Y, F393I, F393V, F415I, F415S, F415V, S443P, A448T, L335F/A448T, S395P/A448T, L393S/A448T, Q408L/A448T, F397L/A448T, I121M/V237I and H440Y/F484Y in terbinafine-resistant isolates.

AB - Background: Dermatophytosis is commonly encountered in the dermatological clinics. The main aetiological agents in dermatophytosis of skin and nails in humans are Trichophyton (T.) rubrum, T. mentagrophytes and T. interdigitale (former T. mentagrophytes-complex). Terbinafine therapy is usually effective in eradicating infections due to these species by inhibiting their squalene epoxidase (SQLE) enzyme, but increasing numbers of clinically resistant cases and mutations in the SQLE gene have been documented recently. Resistance to antimycotics is phenotypically determined by antifungal susceptibility testing (AFST). However, AFST is not routinely performed for dermatophytes and no breakpoints classifying isolates as susceptible or resistant are available, making it difficult to interpret the clinical impact of a minimal inhibitory concentration (MIC). Summary: PubMed was systematically searched for terbinafine susceptibility testing of dermatophytes on October 20, 2020, by two individual researchers. The inclusion criteria were in vitro terbinafine susceptibility testing of Trichophyton (T.) rubrum, T. mentagrophytes and T. interdigitale with the broth microdilution technique. The exclusion criteria were non-English written papers. Outcomes were reported as MIC range, geometric mean, modal MIC and MIC50 and MIC90 in which 50 or 90% of isolates were inhibited, respectively. The reported MICs ranged from <0.001 to >64 mg/L. The huge variation in MIC is partly explained by the heterogeneity of the Trichophyton isolates, where some originated from routine specimens (wild types) whereas others came from non-responding patients with a known SQLE gene mutation. Another reason for the great variation in MIC is the use of different AFST methods where MIC values are not directly comparable. High MICs were reported particularly in isolates with SQLE gene mutation. The following SQLE alterations were reported: F397L, L393F, L393S, H440Y, F393I, F393V, F415I, F415S, F415V, S443P, A448T, L335F/A448T, S395P/A448T, L393S/A448T, Q408L/A448T, F397L/A448T, I121M/V237I and H440Y/F484Y in terbinafine-resistant isolates.

KW - Antifungal susceptibility testing

KW - Dermatophytes

KW - Resistance

KW - Terbinafine

KW - Trichophyton

U2 - 10.1159/000515290

DO - 10.1159/000515290

M3 - Review

C2 - 34058736

AN - SCOPUS:85107546529

VL - 238

SP - 60

EP - 79

JO - Dermatology

JF - Dermatology

SN - 1018-8665

ER -

ID: 273650083